Revvity | PKI - Cash And Equivalent


Revvity reported $860.32M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Agilent USD 1.81B 49M Mar/2026
Align Technology USD 1.06B 35.07M Mar/2026
Bio Techne USD 209.82M 36.94M Mar/2026
Bio-Rad Laboratories USD 507.2M 22.6M Mar/2026
Bruker USD 133.4M 165.4M Mar/2026
Celltrion KRW 56.79B 6.92B Mar/2026
Charles River Laboratories USD 191.83M 21.94M Mar/2026
Cspc Pharmaceutical CNY 7.57B 793.73M Jun/2025
Danaher USD 5.7B 1.09B Mar/2026
Dentsply International USD 190M 136M Mar/2026
Deva Holding AS TRY 775.92M 574.67M Sep/2023
Dianthus Therapeutics USD 627.67M 576.58M Mar/2026
Divis Laboratories Ltd INR 4.15B 31.87B Mar/2025
Edwards Lifesciences USD 2.4B 538M Mar/2026
Illumina USD 1.42B 368M Dec/2025
Intuitive Surgical USD 8.63B 646.3M Jun/2026
IQVIA Holdings USD 1.95B 33M Mar/2026
Kangmei Pharma CNY 1.23B 48.16M Mar/2026
Knight Therapeutics CAD 76.45M 5.43M Dec/2025
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
Laboratory Of America USD 981.1M 448.8M Mar/2026
Malin Corporation EUR 62.1M 26.4M Dec/2024
Medical Developments International AUD 17.84M 219K Jun/2025
Mesa Laboratories USD 28.98M 8.55M Dec/2025
Mettler Toledo International USD 66.89M 2.18M Dec/2025
Myriad Genetics USD 124.4M 25.2M Mar/2026
Neuren Pharmaceuticals AUD 5.91M 2.76M Jun/2025
OraSure Technologies USD 176.96M 22.31M Mar/2026
Organigram Holdings CAD 4.29M 3.28M Mar/2026
Pacific Biosciences Of California USD 56.27M 223.23M Mar/2026
Pharma Mar EUR 48.86M 31.05M Mar/2026
Qiagen NV USD 839M 516.58M Dec/2025
Quest Diagnostics USD 393M 27M Mar/2026
Quidel USD 140.4M 29.4M Mar/2026
Repligen USD 582.65M 16.63M Mar/2026
Revvity USD 860.32M 59.54M Mar/2026
Sartorius EUR 573.8M 32.4M Mar/2026
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Tilray USD 264.83M 43.16M Jun/2025
Waters USD 462M 125.83M Mar/2026
Zealand Pharma A/S 4.58B 1.4B Dec/2025
Zz Pientze Pharmaceu CNY 1.96B 186.63M Mar/2026